Related Experiment Videos
Estimating Chronic Kidney Disease Stage Transitions from Irregular Electronic Health Record Data Using an
Wendy Qi1, Jennifer Mason Lobo1,2,3, Guofen Yan2
1Department of Systems and Information Engineering, University of Virginia, Charlottesville, VA, USA.
Objective:
To estimate chronic kidney disease (CKD) stage transition probabilities in patients with small renal masses (SRMs) using irregularly observed electronic health record (EHR) data, addressing challenges of interval censoring and irregular measurement intervals in real-world clinical practice.
Data Sources:
We used EHR data from the institutional Small Renal Mass registry (2006-January 2026), capturing outpatient renal function data prior to any definitive treatment for SRM. CKD stages were defined using estimated glomerular filtration rate (eGFR) thresholds based on KDIGO guidelines.
Study Design:
The final analytic cohort included 527 patients with at least 2 outpatient eGFR measurements prior to definitive treatment. We applied an expectation-maximization (EM) algorithm to estimate discrete-time CKD stage transition matrices while accounting for irregular eGFR measurement intervals and unobserved intermediate transitions. Transition matrices were estimated under 3- and 6-mo cycle lengths overall as well as stratified by age and sex. The likelihood ratio statistic was used to compare EM-based estimates with the empirical counting estimator.
Results:
The EM framework yielded clinically plausible transition structures dominated by self-transitions and progression primarily to adjacent CKD stages, with reduced spurious backward transitions relative to the empirical estimator. Transition patterns were consistent across 3- and 6-mo cycle lengths. Age-stratified analyses showed that older patients had slightly higher probabilities of progression to more advanced CKD stages compared with younger patients, whereas sex-stratified differences were minimal. Likelihood ratio comparisons supported the consistency of the EM-based models with the observed transition data in both the overall cohort and subgroup analyses.
Conclusions:
The EM approach provides a principled and computationally efficient method for estimating CKD stage progression from irregularly observed EHR data, yielding transition matrices suitable for discrete-time decision-analytic and health economic models.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Kaplan-Meier Approach
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate